GLORIA MELANIE (Chief Operating Officer) sold 1.3% of their position (3.12K shares) of IMMUNOVANT, INC. on the open market
Open‑market sale worth $101.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 5/22/2026ACC: 0001764013-26-000067
Officer· Chief Operating Officer
Since Feb 2026
-3.12K
Net shares
Net seller
$101.1K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
3.12K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−249.00
Price / share
$30.41
Trade value
$7.57K
% of position
0.1%
5/20/2026
245.22K→244.97K
Common Stock
Direct
Shares
−1.17K
Price / share
$32.15
Trade value
$37.55K
% of position
0.5%
5/20/2026
244.97K→243.81K
Common Stock
Direct
Shares
−1.70K
Price / share
$32.95
Trade value
$55.95K
% of position
0.7%
5/20/2026
243.81K→242.11K
Total
Net shares
−3.12K
Net value
-$101.07K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/20/2026 | S · Sale | −249.00 | $30.41 | $7.57K | 0.1% | 245.22K | 244.97K |
| Common Stock Direct | 5/20/2026 | S · Sale | −1.17K | $32.15 | $37.55K | 0.5% | 244.97K | 243.81K |
| Common Stock Direct | 5/20/2026 | S · Sale | −1.70K | $32.95 | $55.95K | 0.7% | 243.81K | 242.11K |
| Total | −3.12K | -$101.07K | ||||||
Derivative Transactions0
No derivative transactions reported